Table 1.

Demographic data of patients with AIH, PBC, and healthy controls. Medication doses and liver test values correspond to the time of serum collection.

	AIH	PBC	Controls
	N=52 (range)	N=42 (range)	N=71 (range)
Age at blood collection, median	54 (20–79)	62 (30–84)	45.0 (21–87)
Female, %	82.7	90.5	70.4
Caucasian, %	84.6	90.5	73.2
Age at diagnosis, median	41 (1.5–71)	52 (26–77)	NA
Cirrhosis (imaging or biopsy), %	55.8	9.5	NA
IAHG* Score, median	17 (6–25)	NA	NA
PBC Stage, median	NA	2 (0–4)	NA
ANA Positive, %	77.0	33.3	NA
AMA Positive, %	3.8	78.6	NA
Prednisone, median daily mg	5.0 (0–60)	NA	NA
Azathioprine, median daily mg	50 (0–150)	NA	NA
Ursodeoxycholic acid, median daily mg	NA	1000 (0–2000)	NA
Alanine Aminotransferase, median U/L	27 (0–383)	29 (10–104)	NA
Alkaline Phosphatase, median IU/L	66 (34–294)	116 (62–423)	NA
Total Bilirubin, median mg/dL	0.51 (0.5–37.1)	0.59 (0.25–50)	NA

^*IAHG – International Autoimmune Hepatitis Group (10).